Connor, Clark & Lunn Investment Management Ltd. Dynavax Technologies Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $21.1 Billion
- Q1 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 336,951 shares of DVAX stock, worth $3.35 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
336,951Holding current value
$3.35 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
311Shares Held
129MCall Options Held
493KPut Options Held
269K-
Black Rock Inc. New York, NY21.9MShares$218 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$177 Million8.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.7MShares$86.5 Million0.0% of portfolio
-
State Street Corp Boston, MA6.79MShares$67.6 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA5.75MShares$57.2 Million4.84% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.26B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...